SOW
DRUG

State of Wyoming’s Bright Minds Biosciences DRUG Stock Holding History

State of Wyoming’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6K Buy
+479
New +$37.6K ﹤0.01% 1741

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State of Wyoming's DRUG Position: Q2 2026 in Review

State of Wyoming opened a new position in Bright Minds Biosciences (DRUG) in Q2 2026: 479 shares worth $33.6K. The stake represents ﹤0.01% of the portfolio and ranks #1741 among its holdings.

100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • State of Wyoming held 479 shares of Bright Minds Biosciences worth $33.6K as of Q2 2026.
  • Bright Minds Biosciences was a new State of Wyoming position in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1741 holding.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.